Surrogate end points. Are they meaningful?
Fisher
D M
DM
D000932:Antiemetics / Q000592:standards*; D002648:Child; D006801:Humans; D015994:Incidence; D009325:Nausea / Q000453:epidemiology / Q000517:prevention & control; D017294:Ondansetron / Q000592:standards*; D011183:Postoperative Complications / Q000453:epidemiology; D014839:Vomiting / Q000453:epidemiology / Q000517:prevention & control
D000932:Antiemetics; D017294:Ondansetron